Ousted Director Says Novartis Inflated Famvir's Value

Law360, New York (November 27, 2007, 12:00 AM EST) -- A former director for Novartis Pharmaceuticals Corp. has sued her former employer, charging that she was fired in retaliation for accusing the company of inflating the future value of the prescription anti-viral medication Famvir.

Carol Shull, the former brand director for Famvir, claims in a lawsuit lodged in New Jersey state court that Novartis decided to exaggerate its future worth when senior managers realized that the $1.63 billion the company paid to acquire the drug was too high. She claims that the company fired her in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.